Douglas Kling
Equibles does not estimate personal net worth.
About Douglas Kling
Earlier roles on record: COO at NewAmsterdam Pharma Co N.V. (NAMS) until August 14, 2026. NewAmsterdam Pharma Co N.V. reported in an 8-K filed July 22, 2026 that Douglas Kling resigned as Chief Operating Officer, effective August 14, 2026.
“On July 16, 2026, Douglas Kling notified NewAmsterdam Pharma Company N.V. (the “Company”) that he would resign as the Company’s Chief Operating Officer, effective August 14, 2026, to be appointed as the chief executive officer of another clinical-stage biotech company.”
Affiliation history
-
Start not stated–2026-08-14